FDA Finalizes Right-to-Try Reporting Requirements
- September 16, 2022
The Food and Drug Administration (FDA) published September 14 (87 Fed. Reg. 56269) a final rule to implement a requirement for sponsors and manufacturers to provide an annual summary to the agency for investigational drugs they provide to patients under the Right to Try Act.
ARTICLE TAGS
You must be logged in to access this content.